Variant report

Variant	rs6909136
Chromosome Location	chr6:132655551-132655552
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:132653758..132656591-chr6:132657655..132660147,2	K562	blood:

Extended variants
information (count: 11 )
Associated
traits (count: 1 )

rSNPs within LD-proxies of this variant (count:9)

rs_ID	r²[population]
rs11968833	0.93[CEU][hapmap];0.84[GIH][hapmap];0.94[TSI][hapmap];0.89[EUR][1000 genomes]
rs1474617	0.95[EUR][1000 genomes]
rs17637818	0.93[CEU][hapmap];0.94[TSI][hapmap];0.89[EUR][1000 genomes]
rs6925859	1.00[CEU][hapmap];0.95[EUR][1000 genomes]
rs73546022	0.95[EUR][1000 genomes]
rs7740843	1.00[CEU][hapmap];0.95[EUR][1000 genomes]
rs7763146	0.94[CHB][hapmap]
rs9321337	0.88[AMR][1000 genomes];0.98[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs9493294	0.94[CHB][hapmap];0.81[CHD][hapmap];0.82[TSI][hapmap]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv886674	chr6:132613798-132694751	ZNF genes & repeats Flanking Active TSS Weak transcription Enhancers Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region miRNA target site	5 gene(s)	inside rSNPs	diseases
2	nsv830811	chr6:132623160-132787539	Enhancers Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region miRNA target site	2 gene(s)	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs6909136	CTGF	cis	parietal	SCAN

Chromatin state (count:41 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:132640400-132662200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr6:132644000-132657400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr6:132644400-132675400	Weak transcription	Fetal Lung	lung
4	chr6:132652000-132665600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
5	chr6:132652800-132657600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr6:132654600-132655600	Enhancers	Muscle Satellite Cultured Cells	--
7	chr6:132654600-132655800	Enhancers	Hela-S3	cervix
8	chr6:132654600-132655800	Flanking Active TSS	HepG2	liver
9	chr6:132654600-132656000	Flanking Active TSS	A549	lung
10	chr6:132654600-132656200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr6:132654600-132656800	Enhancers	Placenta Amnion	Placenta Amnion
12	chr6:132654600-132658400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
13	chr6:132654800-132655600	Enhancers	Osteobl	bone
14	chr6:132654800-132655800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
15	chr6:132654800-132656000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr6:132654800-132656000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
17	chr6:132654800-132656000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
18	chr6:132654800-132656000	Enhancers	Placenta	Placenta
19	chr6:132654800-132656000	Enhancers	NHLF	lung
20	chr6:132654800-132656200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
21	chr6:132654800-132656200	Enhancers	HMEC	breast
22	chr6:132654800-132656200	Enhancers	NHEK	skin
23	chr6:132654800-132656400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr6:132654800-132656800	Enhancers	NHDF-Ad	bronchial
25	chr6:132654800-132657800	Strong transcription	Cortex derived primary cultured neurospheres	brain
26	chr6:132655000-132655600	Flanking Active TSS	Liver	Liver
27	chr6:132655000-132655600	Enhancers	NH-A	brain
28	chr6:132655000-132656000	Enhancers	Fetal Intestine Large	intestine
29	chr6:132655000-132656000	Enhancers	Fetal Intestine Small	intestine
30	chr6:132655000-132656200	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr6:132655000-132656200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
32	chr6:132655000-132656400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr6:132655200-132655600	Enhancers	Stomach Mucosa	stomach
34	chr6:132655200-132655800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr6:132655200-132655800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
36	chr6:132655200-132655800	Enhancers	Fetal Kidney	kidney
37	chr6:132655400-132655600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
38	chr6:132655400-132655600	Enhancers	Duodenum Smooth Muscle	Duodenum
39	chr6:132655400-132655600	Enhancers	HSMMtube	muscle
40	chr6:132655400-132655800	Enhancers	HUVEC	blood vessel
41	chr6:132655400-132656000	Enhancers	Pancreatic Islets	Pancreatic Islet

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links